Page last updated: 2024-08-24

3-iodobenzylguanidine and Cancer Syndromes, Hereditary

3-iodobenzylguanidine has been researched along with Cancer Syndromes, Hereditary in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akker, SA; Drake, WM; LeCain, M; Metcalfe, K; Srirangalingam, U; Tufton, N	1
Giubellino, A; Pacak, K; Shah, U	1
Heymann, WR	1
Duh, QY; Eigelberger, MS	1

Reviews

3 review(s) available for 3-iodobenzylguanidine and Cancer Syndromes, Hereditary

Article	Year
Pheochromocytoma: implications in tumorigenesis and the actual management. Minerva endocrinologica, 2012, Volume: 37, Issue:2 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Agents; Catecholamines; Cell Hypoxia; Combined Modality Therapy; Diagnosis, Differential; Disease Management; Embolization, Therapeutic; Genes, Neurofibromatosis 1; Genetic Predisposition to Disease; Humans; Hypertension; Iodine Radioisotopes; Mutation; Neoplasm Proteins; Neoplastic Syndromes, Hereditary; Pheochromocytoma; Prognosis; Proto-Oncogene Proteins c-ret; Succinate Dehydrogenase; Von Hippel-Lindau Tumor Suppressor Protein	2012
Flushing, pheochromocytoma, and the dermatologist. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Blood Platelets; Flushing; Genes, Tumor Suppressor; Humans; Hypertension; Iodine Radioisotopes; Neoplastic Syndromes, Hereditary; Norepinephrine; Normetanephrine; Pheochromocytoma; Radiopharmaceuticals	2006
Pheochromocytoma. Current treatment options in oncology, 2001, Volume: 2, Issue:4 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenalectomy; Adrenergic alpha-Antagonists; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Catecholamines; Diagnostic Imaging; Humans; Hypertension; Laparoscopy; Metanephrine; Neoplastic Syndromes, Hereditary; Palliative Care; Pheochromocytoma; Tachycardia	2001

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Cancer Syndromes, Hereditary

Article	Year
Four generations of SDHB-related disease: complexities in management. Familial cancer, 2017, Volume: 16, Issue:2 Topics: 3-Iodobenzylguanidine; Adult; Chromogranin A; Early Detection of Cancer; Exons; Genetic Testing; Genotype; Heterozygote; Humans; Laparotomy; Male; Mutation; Neoplastic Syndromes, Hereditary; Norepinephrine; Paraganglioma, Extra-Adrenal; Pedigree; Penetrance; Phenotype; Radionuclide Imaging; Radiosurgery; Succinate Dehydrogenase; Tomography, X-Ray Computed	2017

Article

Year

Four generations of SDHB-related disease: complexities in management.

Familial cancer, 2017, Volume: 16, Issue:2

Topics: 3-Iodobenzylguanidine; Adult; Chromogranin A; Early Detection of Cancer; Exons; Genetic Testing; Genotype; Heterozygote; Humans; Laparotomy; Male; Mutation; Neoplastic Syndromes, Hereditary; Norepinephrine; Paraganglioma, Extra-Adrenal; Pedigree; Penetrance; Phenotype; Radionuclide Imaging; Radiosurgery; Succinate Dehydrogenase; Tomography, X-Ray Computed

2017